/
CYRX
$16.28+$0.28 (+1.75%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$806.4M
50M shares
52-week range
$6.69 – $16.73
96% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change$-45.13
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.6M | $33.9M | $78.7M | $222.6M | $222.6M | $237.3M | $233.3M | $176.2M |
| Cost of revenue | $9.4M | $16.6M | $42.4M | $126.0M | $126.0M | $133.4M | $133.9M | $93.1M |
| Gross profit | $10.2M | $17.4M | $36.3M | $96.6M | $96.6M | $103.9M | $99.3M | $83.1M |
| Gross margin | 52.2% | 51.1% | 46.2% | 43.4% | 43.4% | 43.8% | 42.6% | 47.1% |
| R&D | $1.8M | $3.7M | $9.5M | $16.8M | $16.8M | $15.7M | $18.0M | $17.0M |
| Operating income | −$8.6M | −$17.7M | −$30.0M | −$17.8M | −$17.8M | −$31.9M | −$115.2M | −$36.8M |
| EBITDA | −$8.6M | −$14.5M | −$20.3M | −$248.9M | −$248.9M | −$6.2M | −$66.4M | −$2.1M |
| Net income | −$9.6M | −$18.3M | −$32.7M | −$275.5M | −$275.5M | −$37.3M | −$99.6M | $78.3M |
| Net margin | -48.7% | -54.0% | -41.5% | -123.8% | -123.8% | -15.7% | -42.7% | 44.4% |
| EPS (diluted) | -0.34 | -0.55 | -1.94 | -6.18 | -6.18 | -0.93 | -2.21 | 1.40 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $194M | $-0.78 | $-0.78–$-0.77 | 4 |
| 2027 | $213M | $-0.65 | $-0.66–$-0.65 | 4 |
| 2028 | $230M | $-0.50 | $-0.81–$-0.09 | 3 |
| 2029 | $249M | $-0.55 | $-0.55–$-0.55 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
CryoPort, Inc. Common Stock
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
www.cryoportinc.com- Employees
- 738
- IPO / List date
- Jul 16, 1993
- HQ
- BRENTWOOD, TN
Held by traders on TradeandTell
No one on the platform currently holds CYRX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 368,110 | $3.0M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2015-05-19 | 1-for-12reverse |
| 2010-02-05 | 1-for-10reverse |
| 2005-03-16 | 1.6-for-1 |
Recent trades on TradeandTell
No one on the platform has traded CYRX yet.
